Becker's Healthcare July 3, 2024
An enzyme known as PI3K gamma may be able to reduce organ and tissue damage in patients who have COVID-19 or drug-resistant Staphylococcus aureus, researchers at the University of California San Diego found.
Cancer researchers have previously used the P13K gamma molecule to kill inflammatory cells in tumor tissue and protect the healthy cells and tissue from further damage. Now, they’ve studied the approach on lung tissue infected with SARS-CoV-2 and discovered similar, beneficial results, which were published July 3 in Science Translational Medicine.
The molecule was identified by researchers 12 years ago and in the new research, they discovered the same molecule can be suppressed with a repurposed cancer drug.
PI3K gamma promotes the movement of myeloid cells...
Today's Sponsors
Today's Sponsor